Search Products NEWS

HCY swabs are widely used in research projects, have appeared many times in Nature

Huachenyang (Shenzhen) Tech Co., Ltd. was founded in 2008, and in the 14 years since its establishment, the company has owned 79 patents. It has been focusing on biological consumables and reagents, taking a leading position in the field.

Huachenayng has established good relationships with more than 30 universities, 50 national research institutions, and 200 tertiary hospitals in China. More than 10 experiments/projects published in Nature, Cell, and EClinicalMedicine have chosen Huachenyang’s swabs.

Some of the projects that used Huachenyang’s swabs

Nature Communication

1.

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

Publications: Nature Medicine

Date of publication: 2021


Nature Communication

2.

Microbiota the microbiota continuum along the female reproductive tract and its relation to uterine-related disease

Publications: Nature Communication

Date of publication: 2017


Nature Scientific Reports

3.

Discrepant gut microbiota markers for the classifcation of obesity related metabolic abnormalities

Publications: Nature Scientific Reports

Date of publication: 2019


Nature Scientific Reports

4.

Detection of persistent SARS‑CoV‑2 IgG antibodies in oral mucosal fuid and upper respiratory tract specimens following COVID‑19 mRNA vaccination

Publications: Nature Scientific Reports

Date of publication: 2021


Nature Scientific Reports

5.

Analytic comparison between three high‑throughput commercial SARS‑CoV‑2 antibody assays reveals minor discrepancies in a high‑incidence population

Publications: Nature Scientific Reports

Date of publication: 2021


Nature Scientific Reports

6.

Therapeutic efficacy of macrolides in management of patients with mild COVID‑19

Publications: Nature Scientific Reports

Date of publication: 2021


Nature Scientific Reports

7.

Characterizing the Qatar advanced‑phase SARS‑CoV‑2 epidemic

Publications: Nature Scientific Reports

Date of publication: 2021


Nature Scientific Reports

8.

Gene‑environment interactions between CREB1 and childhood maltreatment on aggression among male Chinese adolescents

Publications: Nature Scientific Reports

Date of publication: 2022


Cell iScience

9.

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

Publications: Nature Cell iScience

Date of publication: 2021


Emerging Microbes & Infections

10.

Human papillomavirus prevalence and associated
factors in women and men in south China: a
population-based study

Publications: Emerging Microbes & Infections

Date of publication: 2016


Eclinical Medicine

11.

SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

Publications: eClinical Medicine

Date of publication: 2021


medRxiv

12.

SARS-CoV-2 reinfection in a cohort of 43,000 antibody positive individuals followed for up to 35 weeks

Publications: medRxiv

Date of publication: 2021

More and more scientific research, medical and governmental institutions choose Huachenyang’s products, which is not only the recognition and trust of our products but also gives us an additional responsibility. Huachenyang will continue to increase its independent research and development investment, actively introduce high-end biotechnology talents and technology, continue to deepen its work in the field of biological consumables and reagents and continue to provide the market with high-quality and stable products.


Huchenyang‘ Flocked Swabs

 Flocked Swabs
Flocked Swabs

Related recommendations

产品中心
Submit your requirementsWe will contact you within 24 hours
Name*
E-mail*
Phone/WhatsApp
ProductsSampling swabsVirus transport mediaRapid test kitsDNA collection kitLab suppliesOthers*
Notes
正在提交中...
提交成功!
提交失败!